Visually inspect hydroxocobalamin solutions for particulate matter and color prior to administration
Maintenance dosing continues at the established effective dose (0.51.0mg) for 1421 days total, administered 3060 minutes before controlled UV exposure when applicable
KLOW Research Protocols and Working Concentrations Because KLOW is a fixed-ratio blend, research protocols are typically expressed as a total blend amount per administration in the model, which then breaks down proportionally across the four compounds (GHK-Cu making up roughly 62.5% of any given amount, with BPC-157, TB-500, and KPV each contributing 12.5%)
318 : 633638 Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT
This documentation prevents confusion when you return to the vial for subsequent doses and helps track any inconsistencies in response that might indicate degradation or error
Occasional reports mention gastrointestinal upset including nausea